Holen Sie sich die Stockscreener-App
12.01
11.50%
-1.56
Handel nachbörslich:
12.61
0.60
+5.00%
Centessa Pharmaceuticals Plc Adr Aktie (CNTA) Neueste Nachrichten
Investor’s Delight: Centessa Pharmaceuticals plc ADR (CNTA) Closes Weak at 13.50, Down -1.53 - DWinneX
Was Centessa Pharmaceuticals plc ADR (CNTA)’s session last reading good? - uspostnews.com
Top investors say Centessa Pharmaceuticals plc ADR (CNTA) ticks everything they need - Sete News
Investor’s Toolkit: Key Ratios for Assessing MSCI Inc (MSCI)’s Performance - DWinneX
Financial Metrics Check: Centessa Pharmaceuticals plc ADR (CNTA)’s Ratios for Trailing Twelve Months - DWinneX
Should investors be concerned about Centessa Pharmaceuticals plc ADR (CNTA)? - uspostnews.com
Parsons Corp (PSN) Shares Up Despite Recent Market Volatility - News Heater
Lantheus Holdings Inc [LNTH] Insider Activity: An Update for Investors - knoxdaily.com
Piper Sandler Initiates Centessa Pharmaceuticals at Overweight With $38 Price Target - MarketScreener
Centessa Pharmaceuticals chief business officer sells $163,386 in stock - Investing.com
Centessa Pharmaceuticals CEO sells shares worth $918,060 By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals CEO sells shares worth $918,060 - Investing.com India
Centessa Pharmaceuticals CAO sells shares worth $120,205 By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals CAO sells shares worth $120,205 - Investing.com India
Centessa Pharmaceuticals’ general counsel sells $98,697 in stock - Investing.com
Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)’s Stock Boosts 3.25%, But It May Be A Worthy Investment - Stocks Register
Ratios Revealed: Decoding Centessa Pharmaceuticals plc ADR (CNTA)’s Financial Health - The Dwinnex
Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight - GlobeNewswire Inc.
Centessa Pharmaceuticals officer sells shares worth $588,943 - Investing.com India
Aegon Ltd (AEG) looking to reclaim success with recent performance - SETE News
Adversity is less terrifying than hope: Wayfair Inc (W) - SETE News
Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News
Taking the lead: Centessa Pharmaceuticals plc ADR (CNTA) - SETE News
Centessa Pharmaceuticals plc ADR (CNTA) Volatility Hits 6.67%: What Good Investors Need To Be Aware Of - Stocks Register
RLI Corp’s (RLI) Stock: A Week-by-Week Analysis - The News Heater
Centessa Pharmaceuticals plc ADR (CNTA) Shares Up Despite Recent Market Volatility - The News Heater
Aon plc (AON) Stock: Evaluating the Market Performance - The News Heater
Qudian Inc ADR (QD) Stock: A Look at the Analyst Recommendations - The News Heater
Examining the Volatility of Costamare Inc’s (CMRE) Stock - The News Heater
Centessa Pharmaceuticals officer Tia Bush sells $185,406 in shares - Investing.com
Financial Fitness Check: Examining Magna International Inc (MGA)’s Key Ratios - The Dwinnex
Financial Metrics Exploration: Understanding Oncolytics Biotech, Inc (ONCY) Through Ratios - The Dwinnex
Financial Health Report: EyePoint Pharmaceuticals Inc (EYPT)’s Ratios Tell a Tale - The Dwinnex
A closer look at Centessa Pharmaceuticals plc ADR (CNTA) is warranted - US Post News
Centessa Pharmaceuticals chief business officer sells shares worth $193,429 - Investing.com India
Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com
Centessa Pharmaceuticals general counsel Hussain Iqbal sells $91,740 in shares - Investing.com
Centessa Pharmaceuticals appoints new Chief Medical Officer - Investing.com
Centessa Pharmaceuticals' chief business officer sells shares worth $170,399 - Investing.com
Centessa Pharmaceuticals CEO sells $959,057 in shares - Investing.com India
Centessa Pharmaceuticals general counsel sells shares for $1.27 million By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals general counsel sells shares for $1.27 million - Investing.com
Stock Market Recap: Tencent Music Entertainment Group ADR (TME) Concludes at 11.30, a -5.68 Surge/Decline - The Dwinnex
Banzai International Inc (NASDAQ: BNZI): Getting A Free Pass? - Stocks Register
Metrics That Matter About Credo Technology Group Holding Ltd (NASDAQ: CRDO) - Stocks Register
Centessa Pharmaceuticals stock hits 52-week high at $18.77 By Investing.com - Investing.com UK
Centessa Pharmaceuticals CEO Saha Saurabh sells $5,450 in shares - Investing.com India
Centessa Pharmaceuticals' chief business officer sells $176,601 in shares - Investing.com
Centessa Pharmaceuticals CEO Saurabh sells shares worth $1.02 million - Investing.com India
Centessa Pharmaceuticals CEO Saurabh sells shares worth $1.02 million By Investing.com - Investing.com South Africa
Deutsche Bank initates Fidelity National Financial Inc (FNF) stock to a Hold - Knox Daily
Centessa Pharmaceuticals CEO sells shares worth $585,418 - Investing.com India
Endava PLC Sponsored ADR (DAVA) Beats Q1 Earnings Estimates - Yahoo Finance
5.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):